BICYCLE THERAPEUTICS PLC Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bicycle Therapeutics Plc quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Bicycle Therapeutics Plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$46.6M, a 8.2% decline year-over-year.
  • Bicycle Therapeutics Plc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$183M, a 24.9% decline year-over-year.
  • Bicycle Therapeutics Plc annual Operating Income (Loss) for 2023 was -$190M, a 62.8% decline from 2022.
  • Bicycle Therapeutics Plc annual Operating Income (Loss) for 2022 was -$117M, a 77.8% decline from 2021.
  • Bicycle Therapeutics Plc annual Operating Income (Loss) for 2021 was -$65.6M, a 26.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$190M -$73.3M -62.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$117M -$51M -77.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$65.6M -$13.7M -26.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$52M -$25.7M -97.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$26.3M -$4.55M -20.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$21.7M -$5.53M -34.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 -$16.2M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.